# Top 10 outcome extracts from lijecnicki vjesnik-139-365_cleaned.json

=== Ranked Outcome 1 (Extract #1, Outcome) — Score: 3 ===
ith N0 or N1 (less than hilar)
Ostale pretrage prema kliničkoj indikaciji (PET samo non-small cell carcinoma: results of the American College of Surgery
Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141(3):
prema preporuci multidisciplinarnog tima).
6. Baumann P, Nyman J, Hoyer M i sur. Outcome in a prospective phase
Diseminirana/neresektabilna lokalno uznapredovala
II trial of medically inoperable stage I non-small-cell lung cancer pa-
bolest u fazi aktivnog liječenja tients treated with stereotactic body radiotherapy. J Clin Oncol 2009;
Kontrola učinka liječenja svakih 6 – 8 tjedana (re

=== Ranked Outcome 2 (Extract #2, Effect) — Score: 1 ===
l lung pemetrexed according to NSCLC histology: a review of two phase III
cancer: a phase III randomised controlled trial. Lancet 2009;374: studies. Oncologist 2009;14:253–63.
379–86. 33. Scagliotti GV, Parikh P, von Pawel J i sur. Phase III study comparing
12. Thomas M, Rübe C, Hoffknecht P i sur. Effect of preoperative chemo- cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemo-
radiation in addition to preoperative chemotherapy: a randomised trial therapy-naive patients with advanced-stage non-small-cell lung cancer.
in stage III non-small cell lung cancer. Lancet Oncol 2008;9:636–4

